Bio Techne Corporation Stock Price Today (NSE: TECH)
Fundamental Score
Bio Techne Corporation Share Price Live NSE/BSE & Institutional Fundamental Analysis
Bio Techne Corporation share price today is ₹35.80, up +0.00% on NSE/BSE as of 17 February 2026. Bio Techne Corporation (TECH) is a Small-cap company in the Specialty Chemicals sector with a market capitalisation of ₹99.58 (Cr). The 52-week high for TECH share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 32.02x, TECH is currently trading above its industry average P/E of 29.20x. The company has a Return on Equity (ROE) of 12.43% and a debt-to-equity ratio of 0.31.
Bio Techne Corporation Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Bio Techne Corporation Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Financial Analysis of Bio Techne Share Price
The specialty chemicals sector, known for its high-margin, low-volume products tailored to specific industries, often commands premium valuations. This is partly due to the intellectual property protection and specialized knowledge required, creating barriers to entry. This analysis provides an overview of the financial stability and key metrics influencing the Bio Techne share price. As of the latest data, the share price stands at ₹38.540001, alongside a Price-to-Earnings (PE) ratio of 32.02 and a Return on Capital Employed (ROCE) of 13.82%.
Bio Techne’s PE ratio of 32.02 suggests a relatively high valuation, indicating investor expectations of future growth. When compared to sector peers like
Amal, a critical factor influencing this premium might be perceived management quality. A deeper dive into corporate governance, strategic decision-making, and capital allocation efficiency could reveal why investors are willing to pay a higher multiple for Bio Techne's earnings compared to Amal.The ROCE of 13.82% is a crucial indicator of Bio Techne’s capital efficiency. This figure represents the return the company generates from its invested capital. A consistently high ROCE, like the 13.82% shown, strengthens the company's economic moat. It implies the business is effectively deploying capital, generating attractive returns and creating a potential competitive advantage that makes it difficult for competitors to erode profitability. However, this needs to be seen in the context of the sector and compared against peers like Bhatia Colour and Deep Polymers to fully assess its competitive positioning.
It's important to view these financial metrics within a broader context, considering factors like debt levels, cash flow generation, and industry trends. A comprehensive understanding requires a thorough examination of the company's financial statements and market dynamics. This observational analysis is part of an 80-parameter fundamental audit, verified by Sweta Mishra, focusing on Bio Techne's financial health. This analysis does not offer any investment advice or recommendations. This analysis serves only as an observational report.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Bio Techne Corporation Fundamental Analysis & Valuation Benchmarking
Educational evaluation of TECH across key market metrics for learning purposes.
Positive Indicators
2 factors identified
Balanced Promoter Holding (71.77%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
3 factors identified
Profit Decline Concern (-42.59%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Limited Institutional Interest (FII+DII: 2.33%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Bio Techne Corporation Financial Statements
Comprehensive financial data for Bio Techne Corporation including income statement, balance sheet and cash flow
About TECH (Bio Techne Corporation)
Bio Techne Corporation (TECH) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Specialty Chemicals sector with a current market capitalisation of ₹99.58 (Cr). Bio Techne Corporation has delivered a Return on Equity (ROE) of 12.43% and a ROCE of 13.82%. The debt-to-equity ratio stands at 0.31, reflecting the company's capital structure. Investors tracking TECH share price can monitor key metrics including P/E ratio, promoter holding of 71.77%, and quarterly earnings growth.
Company Details
Latest News
TECH Share Price: Frequently Asked Questions
What is the current share price of Bio Techne Corporation (TECH)?
As of 17 Feb 2026, 10:24 am IST, Bio Techne Corporation share price is ₹35.80. The TECH stock has a market capitalisation of ₹99.58 (Cr) on NSE/BSE.
Is TECH share price Overvalued or Undervalued?
TECH share price is currently trading at a P/E ratio of 32.02x, compared to the industry average of 29.20x. Based on this relative valuation, the Bio Techne Corporation stock appears to be Overvalued against its sector peers.
What is the 52-week high and low of TECH share price?
The 52-week high of TECH share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Bio Techne Corporation share price?
Key factors influencing TECH share price include quarterly earnings growth (Sales Growth: 5.73%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Bio Techne Corporation a good stock for long-term investment?
Bio Techne Corporation shows a 5-year Profit Growth of N/A% and an ROE of 12.43%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.31 before investing in TECH shares.
How does Bio Techne Corporation compare with its industry peers?
Bio Techne Corporation competes with major peers in the Specialty Chemicals. Investors should compare TECH share price P/E of 32.02x and ROE of 12.43% against the industry averages to determine competitive standing.
What is the P/E ratio of TECH and what does it mean?
TECH share price has a P/E ratio of 32.02x compared to the industry average of 29.20x. Investors pay ₹32 for every ₹1 of annual earnings.
How is TECH performing according to Bull Run's analysis?
TECH has a Bull Run fundamental score of 22.7/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does TECH belong to?
TECH operates in the Specialty Chemicals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Bio Techne Corporation share price.
What is Return on Equity (ROE) and why is it important for TECH?
TECH has an ROE of 12.43%, which shows decent profitability but room for improvement. ROE measures how efficiently Bio Techne Corporation generates profits from shareholders capital.
How is TECH debt-to-equity ratio and what does it indicate?
TECH has a debt-to-equity ratio of 0.31, which indicates moderate leverage that should be monitored.
What is TECH dividend yield and is it a good dividend stock?
TECH offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Bio Techne Corporation shares.
How has TECH share price grown over the past 5 years?
TECH has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in TECH and why does it matter?
Promoters hold 71.77% of TECH shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Bio Techne Corporation.
What is TECH market capitalisation category?
TECH has a market capitalisation of ₹100 crores, placing it in the Small-cap category.
How volatile is TECH stock?
TECH has a beta of N/A. A beta > 1 suggests the Bio Techne Corporation stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is TECH operating profit margin trend?
TECH has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.
How is TECH quarterly performance?
Recent quarterly performance shows Bio Techne Corporation YoY Sales Growth of 5.73% and YoY Profit Growth of -42.59%.
What is the institutional holding pattern in TECH?
TECH has FII holding of 1.09% and DII holding of 1.24%. Significant institutional holding often suggests professional confidence in the Bio Techne Corporation stock.